MALEAH OVERMYER: Open Payments
NPI 1427716554 · BRIDGMAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 7 companies in 2025. Trend: 2023 $850 · 2024 $936 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $96 |
| Novo Nordisk Inc | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
Products named: TRELEGY ELLIPTA, SHINGRIX, LEQVIO, Wegovy, Veozah, Rybelsus, VRAYLAR, Ozempic.
Industry payments across MI — which companies pay providers there.
